| View |
|
DR-XY35419
|
Hypromellose
|
Eye-Mo Moisturizing Formula
|
3 mg/ mL
|
Ophthalmic Solution
|
Lubricant
|
PT Sterling Products Indonesia
|
Indonesia
|
Automatic Renewal
|
08 April 2022
|
14 May 2027
|
| View |
|
DR-XY35422
|
Norethisterone Enanthate + Estradiol Valerate
|
Norifam
|
50 mg/5 mg per mL
|
Solution for Injection (IM)
|
Hormonal Contraceptive
|
Zafa Pharmaceutical Laboratories
(Private) Limited
|
Pakistan
|
Automatic Renewal
|
20 February 2024
|
09 February 2029
|
| View |
|
DR-XY35427
|
Aspirin
|
Aspen
|
100 mg
|
Enteric-Coated Tablet
|
Antithrombotic
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
25 January 2022
|
17 February 2027
|
| View |
|
DR-XY35445
|
Flurbiprofen Sodium
|
FBN
|
0.3 mg/mL ( 0.03 % )
|
Ophthalmic Solution
|
-
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
23 April 2021
|
11 February 2026
|
| View |
|
DR-XY35450
|
Lactated Ringer's Solution
|
RL
|
320mg
|
Solution for Intravenous Infusion
|
-
|
Claris Otsuka Private Limited
|
India
|
Renewal
|
01 June 2021
|
29 April 2026
|
| View |
|
DR-XY35459
|
Aciclovir
|
None
|
400 mg
|
Tablet
|
Antiviral
|
UNILAB, Inc.
|
Philippines
|
Automatic Renewal
|
06 February 2024
|
16 February 2029
|
| View |
|
DR-XY35466
|
Pyrazinamide
|
Zcure Forte
|
500 mg/5 mL
|
Suspension
|
Antituberculosis
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
22 October 2020
|
17 February 2029
|
| View |
|
DR-XY35468
|
Cefuroxime (as axetil)
|
Medzyme
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
16 November 2023
|
18 February 2029
|
| View |
|
DR-XY35471
|
Cefuroxime (as axetil)
|
Medzyme
|
250 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
27 October 2023
|
18 February 2029
|
| View |
|
DR-XY35476
|
Cefuroxime (as axetil)
|
Medzyme
|
125 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
16 November 2023
|
18 February 2029
|
| View |
|
DR-XY35480
|
Piracetam
|
Neurocetam
|
200mg/mL
|
Solution for Injection (IM/IV)
|
Nootropic
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
26 November 2021
|
07 November 2026
|
| View |
|
DR-XY35482
|
Escitalopram
|
Excita
|
10 mg
|
Film Coated Tablet
|
Antidepressant
|
Getz Pharma (Pvt) Ltd.
|
Pakistan
|
Automatic Renewal
|
18 October 2023
|
18 February 2029
|
| View |
|
DR-XY35491
|
Amlodipine (as besilate)
|
Ambloc
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Automatic Renewal
|
20 September 2021
|
04 October 2026
|
| View |
|
DR-XY35505
|
Clevudine
|
Revovir
|
30 mg
|
Capsule
|
Antiviral [Nucleoside/Nucleotide
Transcriptase Inhibitor]
|
Bukwang Pharm. Co., Ltd.
|
Korea
|
Initial [from Monitored Release]
|
30 May 2022
|
07 March 2026
|
| View |
|
DR-XY35511
|
Paracetamol + Phenylpropanolamine hydrochloride +
Chlorphenamine maleate
|
Symdex-D Syrup
|
125 mg/ 6.25 mg/0.5 mg per 5 mL
|
Syrup
|
-
|
Allied Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
29 December 2020
|
25 February 2026
|
| View |
|
DR-XY35512
|
Paracetamol + Phenylpropanolamine hydrochloride +
Chlorphenamine maleate
|
Symdex-D Syrup (Oral Drops)
|
100 mg/ 6.25 mg/0.5 mg per 5 mL
|
Syrup (Oral drops)
|
-
|
Allied Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
29 December 2020
|
25 February 2026
|
| View |
|
DR-XY35521
|
Azelaic Acid
|
Skinoren
|
150 mg/g
|
Gel
|
Anti-Acne
|
Bayer Healthcare Manufacturing S.R.L.
|
Italy
|
Renewal
|
21 December 2023
|
03 March 2029
|
| View |
|
DR-XY35524
|
Co-Amoxiclav
|
Globantin
|
1.2 g
|
Powder For Injection (Iv)
|
Antibacterial (Penicillin)
|
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
|
China
|
Renewal
|
18 February 2024
|
03 March 2025
|
| View |
|
DR-XY35525
|
Amlodipine (as besilate)
|
Solvasc
|
10 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 November 2023
|
03 March 2029
|
| View |
|
DR-XY35545
|
N-Acetyl Aspartyl Glutamic Acid Sodium Salt
|
Naabak
|
49mg/mL
|
Ophthalmic Solution (Eye Drops)
|
Anti-Allergy
|
Excelvision
|
France
|
Renewal
|
16 November 2023
|
13 October 2029
|